Sfoglia per Autore
Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab
2019 De Giorgi, U; Procopio, G; Giannarelli, D; Sabbatini, R; Bearz, A; Buti, S; Basso, U; Mitterer, M; Ortega, C; Bidoli, P; Ferraù, F; Crinò, L; Frassoldati, A; Marchetti, P; Mini, E; Scoppola, A; Verusio, C; Fornarini, G; Cartenì, G; Caserta, C; Sternberg, C
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis
2019 Vernieri, C; Galli, F; Ferrari, L; Marchetti, P; Lonardi, S; Maiello, E; Iaffaioli, R; Zampino, M; Zaniboni, A; De Placido, S; Banzi, M; Damiani, A; Ferrari, D; Rosati, G; Labianca, R; Bidoli, P; Frassineti, G; Nicolini, M; Pavesi, L; Tronconi, M; Buonadonna, A; Ferrario, S; Re, G; Adamo, V; Tamburini, E; Clerico, M; Giordani, P; Leonardi, F; Barni, S; Ciarlo, A; Cavanna, L; Gori, S; Cinieri, S; Faedi, M; Aglietta, M; Antista, M; Dotti, K; Galli, F; Di Bartolomeo, M
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
2019 Landi, L; D'Inca, F; Gelibter, A; Chiari, R; Grossi, F; Delmonte, A; Passaro, A; Signorelli, D; Gelsomino, F; Galetta, D; Giannarelli, D; Soto Parra, H; Minuti, G; Tiseo, M; Migliorino, M; Cognetti, F; Toschi, L; Bidoli, P; Piantedosi, F; Calabro', L; Cappuzzo, F
Liquid biopsy testing can improve selection of advanced non-small-cell lung cancer patients to rechallenge with gefitinib
2019 Esposito Abate, R; Pasquale, R; Sacco, A; Piccirillo, M; Morabito, A; Bidoli, P; Finocchiaro, G; Chiari, R; Foltran, L; Buosi, R; Tiseo, M; Giannetta, L; Battiloro, C; Fasola, G; Romano, G; Ciuffreda, L; Frassoldati, A; de Marinis, F; Cappuzzo, F; Normanno, N
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib
2019 Sharma, G; Cortinovis, D; Agustoni, F; Arosio, G; Villa, M; Cordani, N; Bidoli, P; Bisson, W; Pagni, F; Piazza, R; Gambacorti-Passerini, C; Mologni, L
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity
2019 Cavaletti, G; Cornblath, D; Merkies, I; Postma, T; Rossi, E; Alberti, P; Bruna, J; Argyriou, A; Briani, C; Velasco, R; Kalofonos, H; Psimaras, D; Ricard, D; Pace, A; Faber, C; Lalisang, R; Brandsma, D; Koeppen, S; Kerrigan, S; Schenone, A; Grisold, W; Mazzeo, A; Padua, L; Dorsey, S; Penas-Prado, M; Valsecchi, M; Bidoli, P; Cazzaniga, M
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme
2019 De Giorgi, U; Cartenì, G; Giannarelli, D; Basso, U; Galli, L; Cortesi, E; Caserta, C; Pignata, S; Sabbatini, R; Bearz, A; Buti, S; Lo Re, G; Berruti, A; Bracarda, S; Cognetti, F; Rastelli, F; Fornarini, G; Porta, C; Turci, D; Sternberg, C; Procopio, G; Bidoli, P
Exposure–response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
2018 Smit, E; Garon, E; Reck, M; Cappuzzo, F; Bidoli, P; Cohen, R; Gao, L; O'Brien, L; Lee, P; Zimmermann, A; Ferry, D; Melemed, A; Perol, M
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
2018 Gerber, D; Horn, L; Boyer, M; Sanborn, R; Natale, R; Palmero, R; Bidoli, P; Bondarenko, I; Germonpre, P; Ghizdavescu, D; Kotsakis, A; Lena, H; Losonczy, G; Park, K; Su, W; Tang, M; Lai, J; Kallinteris, N; Shan, J; Reck, M; Spigel, D
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial
2018 Gregorc, V; Gaafar, R; Favaretto, A; Grossi, F; Jassem, J; Polychronis, A; Bidoli, P; Tiseo, M; Shah, R; Taylor, P; Novello, S; Muzio, A; Bearz, A; Greillier, L; Fontana, F; Salini, G; Lambiase, A; O'Brien, M
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
2018 Garassino, M; Cho, B; Kim, J; Mazieres, J; Vansteenkiste, J; Lena, H; Jaime, J; Gray, J; Powderly, J; Chouaid, C; Bidoli, P; Wheatley-Price, P; Park, K; Soo, R; Huang, Y; Wadsworth, C; Dennis, P; Rizvi, N
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
2018 De Placido, S; Gallo, C; De Laurentiis, M; Bisagni, G; Arpino, G; Sarobba, M; Riccardi, F; Russo, A; Del Mastro, L; Cogoni, A; Cognetti, F; Gori, S; Foglietta, J; Frassoldati, A; Amoroso, D; Laudadio, L; Moscetti, L; Montemurro, F; Verusio, C; Bernardo, A; Lorusso, V; Gravina, A; Moretti, G; Lauria, R; Lai, A; Mocerino, C; Rizzo, S; Nuzzo, F; Carlini, P; Perrone, F; Accurso, A; Agostara, B; Aieta, M; Alabiso, O; Alicicco, M; Amadori, D; Amaducci, L; Amiconi, G; Antuzzi, G; Ardine, M; Ardizzoia, A; Aversa, C; Badalamenti, G; Barni, S; Basurto, C; Berardi, R; Bergamasco, C; Bidoli, P; Bighin, C; Biondi, E; Bisagni, G; Boni, C; Borgonovo, K; Botta, M; Bravi, S; Bruzzi, P; Buono, G; Butera, A; Caldara, A; Candeloro, G; Cappelletti, C; Cardalesi, C; Carfora, E; Cariello, A; Carrozza, F; Carteni, G; Caruso, M; Casadei, V; Casanova, C; Castori, L; Cavanna, L; Cavazzini, G; Cazzaniga, M; Chilelli, M; Chiodini, P; Chiorrini, S; Ciardiello, F; Ciccarese, M; Cinieri, S; Clerico, M; Coccaro, M; Comande, M; Corbo, C; Cortino, G; Cusenza, S; Daniele, G; D'Arco, A; D'Auria, G; Dazzi, C; De Angelis, C; de Braud, F; De Feo, G; De Matteis, A; De Tursi, M; Di Blasio, A; di Lucca, G; Di Lullo, L; Di Rella, F; Di Renzo, G; Di Stefano, P; Di Stefano, A; Diana, A; Donati, S; Fabbri, A; Fabi, A; Faedi, M; Farina, G; Farris, A; Febbraro, A; Fedele, P; Federico, P; Ferrau, F; Ferretti, G; Ferro, A; Floriani, I; Forcignano, R; Forciniti, S; Forestieri, V; Fornari, G; Frisinghelli, M; Fusco, V; Gallizzi, G; Galvano, A; Gambardella, A; Gambi, A; Gebbia, V; Gervasi, E; Ghilardi, M; Giacobino, A; Giardina, G; Giotta, F; Giraudi, S; Giuliano, M; Grassadonia, A; Grasso, D; Grosso, F; Guizzaro, L; Incoronato, P; Incorvaia, L; Iodice, G; La Verde, N; Labonia, V; Landi, G; Latorre, A; Leonardi, V; Levaggi, A; Limite, G; Lina Bascialla, L; Livi, L; Maiello, E; Mandelli, D; Marcon, I; Menon, D; Montedoro, M; Moraca, L; Moretti, A; Morritti, M; Morselli, P; Mura, A; Mura, S; Musacchio, M; Muzio, A; Natale, D; Natoli, C; Nigro, C; Nistico, C; Nuzzo, A; Orditura, M; Orlando, L; Pacilio, C; Palumbo, G; Palumbo, R; Pasini, F; Paterno, E; Pazzola, A; Pelliccioni, S; Pensabene, M; Perroni, D; Pesenti Gritti, A; Petrelli, F; Piccirillo, M; Pinotti, G; Pogliani, C; Poli, D; Prader, S; Recchia, F; Rizzi, D; Romano, C; Rossello, R; Rossini, C; Salvucci, G; Sanna, V; Santini, A; Saracchini, S; Savastano, C; Scambia, G; Schettini, F; Schiavone, P; Schirone, A; Seles, E; Signoriello, S; Signoriello, G; Silva, R; Silvestri, A; Simeon, V; Spagnoletti, I; Tamberi, S; Teragni, C; Thalmann, V; Thomas, R; Thomas, G; Tienghi, A; Tinari, N; Tinessa, V; Tomei, F; Tonini, G; Torri, V; Traficante, D; Tudini, M; Turazza, M; Vignoli, R; Vitale, M; Zacchia, A; Zagarese, P; Zanni, A; Zavallone, L; Zavettieri, M; Zoboli, A
Challenges in ALK inhibition of ALK-positive non-small-cell lung cancer: From ALK positivity detection to treatment strategies after relapse
2018 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Cogliati, V; Bidoli, P
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.
2018 Cerrito, M; De Giorgi, M; Pelizzoni, D; Bonomo, S; Digiacomo, N; Scagliotti, A; Bugarin, C; Gaipa, G; Grassilli, E; Lavitrano, M; Giovannoni, R; Bidoli, P; Cazzaniga, M
Efficacy and safety of vinorelbine-capecitabine oral metronomic combinaton in elderly metastatc breast cancer patents: VICTOR-1 study
2017 Cazzaniga, M; Torri, V; Riva, F; Porcu, L; Cicchiello, F; Capici, S; Cortinovis, D; Digiacomo, N; Bidoli, P
A new race against lung cancer
2017 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
2017 Gligorov, J; Ataseven, B; Verrill, M; de Laurentiis, M; Jung, K; Azim, H; Al-Sakaff, N; Lauer, S; Shing, M; Pivot, X; Koroveshi, D; Bouzid, K; Casalnuovo, M; Cascallar, D; Korbenfeld, E; Bastick, P; Beith, J; Colosimo, M; Friedlander, M; Ganju, V; Green, M; Patterson, K; Redfern, A; Richardson, G; Ceric, T; Gordana, K; Beato, C; Ferrari, M; Hegg, R; Helena, V; Ismael, G; Lessa, A; Mano, M; Morelle, A; Nogueira, J; Timcheva, K; Tomova, A; Tsakova, M; Zlatareva-Petrova, A; Asselah, J; Assi, H; Brezden-Masley, C; Chia, S; Freedman, O; Harb, M; Joy, A; Kulkarni, S; Prady, C; Gaete, A; Matamala, L; Torres, R; Yanez, E; Franco, S; Urrego, M; Gugic, D; Vrbanec, D; Melichar, B; Prausova, J; Vyzula, R; Pilarte, R; Leon, M; Munoz, R; Ramos, G; Azeem, H; Aziz, A; El Zawahry, H; Osegueda, F; Alexandre, J; Artignan, X; Barletta, H; Beguier, E; Berdah, J; Marty, C; Bollet, M; Bourgeois, H; Bressac, C; Burki, F; Campone, M; Coeffic, D; Cojocarasu, O; Dagada, C; Dalenc, F; Del Piano, F; Desauw, C; Desmoulins, I; Dohollou, N; Egreteau, J; Ferrero, J; Foa, C; Garidi, R; Gasnault, L; Guardiola, E; Hamizi, S; Jarcau, R; Jacquin, J; Jaubert, D; Jolimoy, G; Mineur, H; Largillier, R; Leduc, B; Martin, P; Melis, A; Monge, J; Moullet, I; Mousseau, M; Nguyen, S; Orfeuvre, H; Petit, T; Priou, F; Bach, I; Simon, H; Stefani, L; Uwer, L; Youssef, A; Aktas, B; von der Assen, A; Augustin, D; Balser, C; Bauer, L; Bechtner, C; Beyer, G; Brucker, C; Buckner, U; Busch, S; Christensen, B; Deryal, M; Farrokh, A; Faust, E; Friedrichs, K; Graf, H; Griesshammer, M; Grischke, E; Hanle, C; Heider, A; Henschen, S; Hesse, T; Jackisch, C; Kisro, J; Kohler, A; Kuemmel, S; Lampe, D; Lantzsch, T; Latos, K; Lex, B; Liedtke, C; Luedders, D; Maintz, C; Muller, V; Overkamp, F; Park-Simon, T; Paul, M; Prechtl, A; Ringsdorf, U; Runnebaum, I; Ruth, S; Salat, C; Scheffen, I; Schilling, J; Schmatloch, S; Schmidt, M; Schneeweiss, A; Schrader, I; Seipelt, G; Simon, E; Stefek, A; Stickeler, E; Thill, M; Tio, J; Tuczek, A; Warm, M; Weigel, M; Wischnik, A; Wojcinski, S; Ziegler-Lohr, K; Aravantinos, G; Ardavanis, A; Fountzilas, G; Gogas, H; Kakolyris, S; Mavroudis, D; Papadimitriou, C; Papandreou, C; Papazisis, K; Castro, H; Hernandez-Monroy, C; Ngan, R; Yeo, W; Bittner, N; Boer, K; Csejtei, A; Horvath, Z; Kocsis, J; Mangel, L; Mezei, K; Nagy, Z; Szanto, J; Atmakusuma, D; Fadjari, H; Kurnianda, D; Prayogo, N; Tanggo, E; Coate, L; Hennessy, B; Kelly, C; Martin, M; Nasim, S; O'Connor, M; Aieta, M; Allegrini, G; Amadori, D; Bidoli, P; Biti, G; Bordonaro, R; Bottini, A; Carterni, G; Cavanna, L; Cazzaniga, M; Cognetti, F; Contu, A; Cruciani, G; Donadio, M; Falcone, A; Farci, D; Forcignano, R; Frassoldati, A; Gaion, F; Gamucci, T; Giotta, F; Livi, L; Lorusso, V; Maiello, E; Marchetti, P; Mariani, G; Mion, M; Moscetti, L; Musolino, A; Pazzola, A; Pedrazzoli, P; Pigi, A; de Placido, S; Caremoli, E; Santoro, A; Tienghi, A; Ahn, J; Lee, K; Lee, S; Seo, J; Sohn, J; Cesas, A; Juozaityte, E; Cheah, N; Chong, F; Devi, B; Phua, V; Teoh, D; Ching, L; Yusof, M; Corona, J; Dominguez, A; Mendoza, R; Hernandez, C; Ramiro, A; Santos, J; Espinosa, P; Villarreal Garza, C; Errihani, H; Bakker, S; van den Berkmortel, F; Blaisse, R; Huinink, D; van den Bosch, J; Braun, J; Dercksen, M; Droogendijk, H; Erdkamp, F; Haringhuizen, A; de Jongh, F; Kok, T; Los, M; Madretsma, S; Terwogt, J; van der Padt, A; van Rossum-Schornagel, Q; Smilde, T; de Valk, B; van der Velden, A; van Warmerdam, L; van de Wouw, A; North, R; Kersten, C; Mjaaland, I; Wist, E; Aziz, Z; Masood, N; Rashid, K; Shah, M; Alcedo, J; Aleman, D; Neciosup, S; Reategui, R; Valdiviezo, N; Vera, L; Fernando, G; Roque, F; Strebel, H; Krzemieniecki, K; Litwiniuk, M; Mruk, A; Pienkowski, T; Sawrycki, P; Slomian, G; Tomczak, P; Afonso, N; Cardoso, F; Damasceno, M; Nave, M; Badulescu, F; Ciule, L; Curescu, S; Eniu, A; Filip, D; Grecea, D; Jinga, D; Lungulescu, D; Oprean, C; Stanculeanu, D; Turdean, M; Dvornichenko, V; Emelyanov, S; Lichinitser, M; Manikhas, A; Sakaeva, D; Shirinkin, V; Stroyakovskiy, D; Abulkhair, O; Zekri, J; Filipovic, S; Kovcin, V; Nedovic, J; Pesic, J; Vasovic, S; Ng, R; Bystricky, B; Leskova, J; Mardiak, J; Misurova, E; Wagnerova, M; Takac, I; Demetriou, G; Dreosti, L; Govender, P; Jordaan, J; Veersamy, P; Romero, J; Lopez, N; Arias, C; Chacon, J; Aramburo, A; Morales, L; Garcia, M; Estevez, L; Garcia-Palomo Perez, A; Garcia Saenz, J; Garcia Sanchis, L; Cubells, L; Cortijo, L; Santiago, S; De Aranguiz, B; Manas, J; Gallego, P; Cussac, A; Ferrandiz, C; Garrido, M; Alvarez, P; Vega, J; Del Prado, P; Janez, N; Murillo, S; Rosales, A; Jaso, L; Fernandez, I; Martorell, A; Carrion, R; Simon, S; Alcibar, A; Lorenzo, J; Garcia, V; Asensio, T; Maicas, M; Villanueva Silva, M; Killander, F; Svensson, J; Fehr, M; Hauser, N; Muller, A; Pagani, O; Passmann-Kegel, H; Popescu, R; Rabaglio, M; Rauch, D; Schlatter, C; Zaman, K; Chang, T; Huang, C; Wang, H; Yu, J; Bandidwattanawong, C; Maneechavakajorn, J; Seetalarom, K; Dejthevaporn, T; Somwangprasert, A; Vongsaisuwon, M; Akbulut, H; Altundag, K; Arican, A; Bozcuk, H; Eralp, Y; Idris, M; Isikdogan, A; Senol, C; Sevinc, A; Uygun, K; Yucel, E; Yucel, I; Yumuk, F; Shparyk, Y; Voitko, N; Jaloudi, M; Adams, J; Agrawal, R; Ahmed, S; Alhasso, A; Allerton, R; Anwar, S; Archer, C; Ashford, R; Barraclough, L; Bertelli, G; Bishop, J; Branson, T; Butt, M; Chakrabarti, A; Chakraborti, P; Churn, M; Crowley, C; Davis, R; Dhadda, A; Eldeeb, H; Fraser, J; Hall, J; Hickish, T; Hogg, M; Howe, T; Joffe, J; Kelleher, M; Kelly, S; Kendall, A; Kristeleit, H; Lumsden, G; Macmillan, C; Macpherson, I; Malik, Z; Mithal, N; Neal, A; Panwar, U; Proctor, A; Proctor, S; Raj, S; Rehman, S; Sandri, I; Scatchard, K; Sherwin, E; Sims, E; Singer, J; Smith, S; Tahir, S; Taylor, W; Tsalic, M; Wardley, A; Waters, S; Wheatley, D; Wright, K; Yuille, F; Alonso, I; Artagaveytia, N; Rodriguez, R; Arbona, E; Garcia, Y; Lion, L; Marcano, D; Van Thuan, T
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2017 Martin, M; Holmes, F; Ejlertsen, B; Delaloge, S; Moy, B; Iwata, H; von Minckwitz, G; Chia, S; Mansi, J; Barrios, C; Gnant, M; Tomasevic, Z; Denduluri, N; Separovic, R; Gokmen, E; Bashford, A; Borrego, M; Kim, S; Jakobsen, E; Ciceniene, A; Inoue, K; Overkamp, F; Heijns, J; Armstrong, A; Link, J; Abraham, A; Bryce, J; Wong, A; Moran, S; Yao, B; Xu, F; Auerbach, A; Buyse, M; Chan, A; Bidoli, P
EAGLES study: First-line bevacizumab in combination with chemotherapy in elderly patients with advanced, metastatic, non-squamous non-small cell lung cancer
2017 De Marinis, F; Bidoli, P; Luciani, A; Amoroso, D; Tonini, G; Bertolini, A; Brandes, A; Migliorino, M; Favaretto, A; Gridelli, C
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: Analysis of 318 patients
2017 Canova, S; Cicchiello, F; Agustoni, F; Bianchini, G; Abbate, M; Bidoli, P; Cortinovis, D
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile